First name,Last name,Preferred title,Overview,Position,Department,Individual
Kayla,Bayless,Associate Professor,"My laboratory conducts research in two areas of molecular and cellular medicine: the mechanism through which primary human endothelial cells invade into 3D matrices, and communication between invading endothelial cells and their surrounding 3D collagen matrix.",Associate Professor,Cell Biology and Genetics,https://scholars.library.tamu.edu/vivo/display/n1dd3799c
Lisa,Even,Manager Laboratory,,Manager Laboratory,Small Animal Clinical Sciences,https://scholars.library.tamu.edu/vivo/display/n24b36cbf
Thomas,Kent,Professor,"Neurologist and clinician scientist with a basic, translational and clinical research program, focused mostly on stroke and other brain injuries. The laboratory utilizes a variety of cell free, tissue culture and in-vivo techniques to design and characterize a series of carbon nanomaterials that possess the ability to act as catalytic antioxidants as well as support key mitochondrial functions. This NIH-supported research is in collaboration with synthetic nano-chemists at Rice University (Tour Lab) and biochemists at University of Texas Health Science Center Houston (Tsai Lab). The group is testing a variety of engineered modifications of these versatile, non-toxic materials to address specific cell injury and death mechanisms including ferroptosis and interruption in electron transport and oxidative phosphorylation.
A major interest of ours is the role of diabetes in worsening outcome from stroke, a condition that affects minority and rural Texans disproportionally. With a range of research from molecular interactions to whole animal and clinical studies, the work in this lab is deeply translational, leveraging the group's clinical training and experience to insure that conclusions have direct relevance to the disease state, with the ultimate goal of facilitating the identification of new therapies for these major contributors to disability and mortality.",Professor,Institute of Biosciences and Technology,https://scholars.library.tamu.edu/vivo/display/n4acd1da6
Gwendolyn,Levine,Clinical Associate Professor,,Clinical Associate Professor,Veterinary Pathobiology,https://scholars.library.tamu.edu/vivo/display/n68f0c0ae
Jonathan,Levine,Professor and Head,,Professor and Head,Small Animal Clinical Sciences,https://scholars.library.tamu.edu/vivo/display/n8ae2a0a7
Nicholas,Jeffery,Professor,,Professor,Small Animal Clinical Sciences,https://scholars.library.tamu.edu/vivo/display/n989eab0c
Bani,Mallick,Distinguished Professor,"Bayesian hierarchical Modeling, Nonparametric Regression and classification, Bioinformatics, Spatio-temporal Modeling, Machine learning, Functional Data analysis, Bayesian nonparametrics, Petroleum reservoir characterization, Uncertainty analysis of Computer Model outputs",Distinguished Professor,Statistics,https://scholars.library.tamu.edu/vivo/display/na73654e3
Virginia,Fajt,Clinical Professor,,Clinical Professor,School of Veterinary Medicine and Biomedical Sciences,https://scholars.library.tamu.edu/vivo/display/naed06733
Stephen,Safe,Distinguished Professor,The aryl hydrocarbon receptor (AhR) is a nuclear helix-loop-helix transcription factor which forms a ligand-induced nuclear heterodimer with the AhR nuclear translocator (Arnt) protein. Research in this laboratory is focused on the molecular mechanism of crosstalk between the AhR and estrogen receptor (ER) signaling pathways in which the AhR inhibits estrogen-induced gene expression. The antiestrogenic activities of some AhR agonists are also being developed as drugs for clinical treatment of breast and endometrial cancers in women. Research on estrogen-dependent gene expression in various cancer cell lines is focused on analysis of several gene promoters to determine the mechanisms of ERa and ERb action. This includes several genes that are activated through interactions of the ER with Sp1 protein and other DNA-bound transcription factors.,Distinguished Professor||Distinguished Professor||Syd Kyle Chair,School of Veterinary Medicine and Biomedical Sciences||Biochemistry and Biophysics||Veterinary Physiology and Pharmacology,https://scholars.library.tamu.edu/vivo/display/nb20fdbd9
Jonathan,Lidbury,Assistant Professor,,Assistant Professor,Small Animal Clinical Sciences,https://scholars.library.tamu.edu/vivo/display/nb52ba3ea
Raquel,Sitcheran,Associate Professor,"The goal of our research is to understand the molecular mechanisms that control NF-kappaB regulatory networks in the central nervous system (CNS). NF-kappaB is a ubiquitously expressed, evolutionarily conserved transcription factor that responds to a variety of signals and regulates fundamental processes, including cell growth and proliferation, inflammation, invasion and angiogenesis. Indeed, aberrant NF-kappaB activity or expression is associated with many cancers, as it can promote tumorigenesis, tumor progression and resistance to therapy. Our focus is on glioblastoma, a common and highly lethal CNS tumor that is very resistant to current treatment strategies.",Associate Professor,The Texas A&M University System,https://scholars.library.tamu.edu/vivo/display/nb97a02a1
Ashok,Shetty,Professor and Associate Director,"Dr. Ashok K. Shetty's laboratory is interested in developing clinically applicable strategies efficacious for enhancing brain function after injury, disease, or aging. The central areas of investigation are focused on:
o Mechanisms by which intranasally administered stem cell-derived extracellular vesicles (EVs) promote neuroprotection, neuroregeneration, neural plasticity, and alleviate neuroinflammation. The sources of EVs include human bone marrow mesenchymal stem cells (hMSCs), and human induced pluripotent stem cell-derived neural stem cells (hiPSC-NSCs), astrocytes, and microglia. The model systems include traumatic brain injury (TBI), closed head injury (CHI), Aging, Alzheimer's disease (AD) and temporal lobe epilepsy (TLE).
o Mechanisms by which transplanted human neural stem cells or human GABA-ergic precursor cells derived from hiPSCs promote brain repair, and alleviate spontaneous seizures, and cognitive and mood impairments in prototypes of SE, TLE, and TBI.
o Elucidating mechanisms of brain dysfunction and chronic neuroinflammation in prototypes of Gulf War Illness. Developing therapeutic strategies to alleviate neuroinflammation, systemic inflammation, and cognitive and mood impairments in models of GWI.
o Developing clinically feasible strategies for improving brain function in aging and AD models via stimulation of endogenous neural stem cells using drugs and biologics.
Dr. Shetty has received continuous extramural research funding as PI for >25 years from sources such as the NIH, DOD, Dept of Veterans Affairs (VA), and industry. These include seven R01 grant awards and an R21 grant award from the NIH; seven CDMRP grant awards from the DOD; five Merit Grant awards and two Research Career Scientist Awards from the VA; and two industry grants. He has also served as Co-I of 8 other DOD grants. Grants from the NIH, DOD, and industry fund Dr. Shetty's current research. Dr. Shetty has authored 181 peer-reviewed publications (147 as senior/first author) and edited a book on Neural Stem Cells in Health and Disease. His work has appeared in many prestigious and high-impact journals. Dr. Shetty has received >17,000 citations for his publications with an h-index of 64. Dr. Shetty has the distinction of serving on two NIH Study Sections and one VA study section as a Chartered Member. Besides, he has served as a member of many other study section panels of the NIH, DOD, VA, and Maryland State Stem Cell Research Fund. Dr. Shetty is Co-Editor-in-Chief of the journal, Aging & Disease and Associate Editor of 6 Neuroscience journals. He is also a Member of the Editorial Board of many prestigious journals, including The Journal of Extracellular Vesicles, Aging Cell, and Stem Cells. Dr. Shetty is a Fellow of the American Society for Neural Transplantation and Repair. Dr. Shetty received the Senior Research Excellence Award in 2021 from the TAMU College of Medicine and is among the ""World's Top 2% Scientists"" across all scientific fields.","Associate Director, Institute for Regenerative Medicine||Professor",Cell Biology and Genetics||Cell Biology and Genetics,https://scholars.library.tamu.edu/vivo/display/nba613a86
Brian,Porter,Clinical Professor,Comparative neuropathology; canine gliomas and canine spinal trauma as models for the human conditions; wildlife disease and environmental conservation,Clinical Professor,Veterinary Pathobiology,https://scholars.library.tamu.edu/vivo/display/nc00264c7
Pamela,Ferro,"Section Head, Molecular Diagnostics",,"Section Head, Molecular Diagnostics||Adjunct Faculty",Texas A&M Veterinary Medical Diagnostic Laboratory||Veterinary Pathobiology,https://scholars.library.tamu.edu/vivo/display/nc1e62471
Gang,Han,Professor,"My research efforts have been in Statistics, Computer Science, and their applications to Biomedical Research and Bioinformatics. I have been working on the design and analysis of complex computer models since 2004. I developed statistical approaches for modeling the output from complex computer codes having quantitative and qualitative inputs, as well as the calibration and tuning for computer models. My recent research includes modeling cancer survivorship data, modeling epidemiological data, and applying statistical learning tools to the early detection of ovarian cancer.",Professor,Epidemiology and Biostatistics,https://scholars.library.tamu.edu/vivo/display/neb4e64eb
Roger,Smith,Professor,Application of flow cytometry to study of animal disease and clinical veterinary medicine; core flow cytometry laboratory.,Professor,Veterinary Pathobiology,https://scholars.library.tamu.edu/vivo/display/nefd6ee54
Edward,Dougherty,Distinguished Professor,My research focuses on genomic signal processing and image analysis.,Distinguished Professor,Electrical and Computer Engineering,https://scholars.library.tamu.edu/vivo/display/nf4ef0ac5
Jiang,Chang,Professor,"Heart failure (impaired ventricular pump function) is an eventual outcome for diverse cardiovascular disorders and the leading cause of combined morbidity and mortality in the United States and other developed industrial nations. The focus of my lab is to understand the molecular and cellular mechanisms that initiate and mediate the pathogenesis of maladaptive cardiac remodeling, such as cardiac hypertrophy and fibrosis as result of various pathological scenarios such as myocardial infarction, hypertension, obesity, diabetes, aging and post-traumatic stress disorder. The overall approach consists of generation and analysis of clinically-relevant genetic mouse models including a tool mouse enabling tracking endogenous cardiac exosomes, and conduct mechanistic studies using cutting-edge technology. The ultimate goal of our efforts is to provide clinical translation for the prevention and treatment of pathological cardiac remodeling from our mechanistic studies.",Professor,Center for Genomic and Precision Medicine,https://scholars.library.tamu.edu/vivo/display/nf80a9dad
Magnus,Hook,Professor,"The primary interest of our laboratory is to try to understand the structural function of the extracellular matrix. Of particular interest is the study of the molecular mechanisms of microbial adhesion to host tissue. This process, which is believed to represent a critical initial step in the development of infections, involves specific cell-surface proteins that recognize and bind with a high affinity to components in the host tissue. Our goal is to decipher these events at a molecular level and, based on structural analysis of the interacting components, design new strategies to prevent and treat infections.",Regents & Distinguished Professor and Director,Center for Infectious and Inflammatory Diseases,https://scholars.library.tamu.edu/vivo/display/nfd8d37d6